Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac abnormalities at some point during the progression of their disease, the most common of which is heart blockage of varying degrees. Such blockage is characterized by conduction defects and supraventricular and ventric...
Main Authors: | Mouli Chakraborty, Estela Selma-Soriano, Emile Magny, Juan Pablo Couso, Manuel Pérez-Alonso, Nicolas Charlet-Berguerand, Ruben Artero, Beatriz Llamusi |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2015-12-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/8/12/1569 |
Similar Items
-
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA<sup>LR</sup> Mice
by: Sarah J. Overby, et al.
Published: (2023-03-01) -
(CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis
by: Vildan Betul Yenigun, et al.
Published: (2017-08-01) -
Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
by: Sarah J. Overby, et al.
Published: (2022-03-01) -
Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
by: Marta López-Morató, et al.
Published: (2018-05-01) -
Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
by: Lubov Timchenko
Published: (2022-09-01)